←
David Carbone MD29 posts
David Carbone MD avatar

David Carbone MD

@DCarboneMD
◷ Joined March 2015
David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

Have to go, but even though new therapies give hope, there is still a lot of room for improvement and need for research.

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

Things are changing so fast it is hard to keep up with the new treatments. Second opinions help. Also join IASLC and go to World Lung Conf.

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

It would be really interesting to do liquid biopsies in combination with LDCT screening, and people (including us) are starting to do it

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

Definitely - there are many slightly different ones, as well as several completely different classes of drugs and combos with standard ones

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

We don't currently have a test that is perfect for finding out who benefits, but PDL1 staining is a step in that direction

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

Cancers suppress the immune system to avoid being killed by it. Immunotherapies today "unmask" the tumor and allow it to do its job

David Carbone MD avatar
David Carbone MD@DCarboneMD·8 May 2015

I view it as finding the optimal treatment for each patient based on the molecular features of that patient and their tumor